Delivery Order SPE2DR25D9101-SPE2DR26FKTA7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,521.66 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 133mg/10ml (10 units). The award was issued on August 7, 2025, with an ultimate completion date of August 26, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Park Ridge location. This delivery order carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The award, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This...
- The Defense Logistics Agency (DLA) awarded a $20,085.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $17,574.41 to DMS Pharmaceutical Group Inc. on August 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, allowing...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL (133 mg/10 mL vial). This firm fixed-price delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,730.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $26,113.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, indicating the award was made through competitive procurement. The delivery order is issued under DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract, valued at approximately $25.1K, carries an ultimate completion date of September 29, 2025, and was issued on September 8, 2025. This delivery order does not utilize a set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $10,550.54 firm fixed-price delivery order on May 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the supply of EXPAREL 133 mg/10 ml vials. The award carries an ultimate completion date of June 3, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DR25D9101Indefinite Delivery Contract
- SPE2DR25D9101-SPE2DR26FKTA7Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,108.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 133 mg/10 mL vials. This delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, carries no set-aside designation, indicating that DMS Pharmaceutical Group competed successfully in an unrestricted procurement. The delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for Department of Defense pharmaceutical supply needs. DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the federal military medical system, with its PPV-G GEN V prime vendor contract carrying a ceiling value of $499.9 million through December 31, 2036. The contract authorizes the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. EXPAREL, a specialty surgical anesthetic product, represents one of the specialized pharmaceutical offerings within the company's diverse product portfolio, which has demonstrated consistent performance across multiple therapeutic categories and delivery order values ranging from under $100 to over $115,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/4/25 |